H.C. Wainwright Maintains Atossa Therapeutics(ATOS.US) With Buy Rating, Maintains Target Price $6

Moomoo NewsOct 31 10:31 ET · Ratings

Express News | Atossa - (Z)-Endoxifen at 10 Mg Once Daily Met Primary Endpoint With 19/20 (95%) Receiving > 75 % of Planned Treatment in I-Spy-2 Phase 2 Trial

ReutersOct 31 08:15 ET

Express News | Atossa Therapeutics Releases Promising Preliminary Analysis Demonstrating (Z)-Endoxifen’s Potential to Rapidly Reduce Ki-67 and Tumor Volume in Er+/Her2- Breast Cancer

ReutersOct 31 08:15 ET

Atossa Therapeutics to Participate in Fireside Chat With Karolinska Institute at BIO-EUROPE 2024 to Discuss a Unique Swedish American Collaboration to Prevent Breast Cancer

GlobeNewswireOct 21 08:30 ET

Breast Cancer Awareness Month Sees Biotech Advancements and Worrying Trends for Young Women

PR NewswireOct 15 07:32 ET

Atossa Therapeutics Announces Recognition of Breast Cancer Awarenss Month

TipRanksOct 1 08:41 ET